Solid Biosciences公布2026年展望,强调神经肌肉与心脏管线进展及新一代衣壳AAV-SLB101的扩大可及性

美股速递
Jan 14

Solid Biosciences(纳斯达克代码:SLDB)近日发布了其2026年战略展望,重点突出了公司在神经肌肉疾病和心脏疾病治疗管线方面取得的显著进展。报告同时披露,公司下一代基因治疗衣壳AAV-SLB101的可及性将进一步扩大,为更多患者带来希望。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10